During a keynote address at HIMSS, Hackensack Meridian Health CEO Robert Garrett outlined four priorities that should guide healthcare organizations' AI strategies. He said that healthcare leaders need to take care to ensure their AI efforts seek to address one if not all of these.
Join MedCity News and nearly 300 healthcare investors, startups, and innovative-minded executives in Chicago at the Ritz Carlton on May 21-22. Space is limited. Secure your spot today to attend!
Tubulis's next-generation ADC cancer drugs are designed to overcome limitations of currently available therapies in this drug class. The new financing will support clinical trial plans, but first, preclinical proof-of-concept data will be presented during the American Association for Cancer Research annual meeting.
The emergence of artificial intelligence (AI) offers a glimmer of hope in the fight against STDs and has the power to revolutionize the landscape of STD detection, treatment, and prevention.
In this episode of the MedCity Pivot Podcast, we looked deeper into Lumen, a consumer device meant to give people better understanding over how the body burns fat or carbs. We caught up with Daniel Tal Mor, CEO of Lumen, at Vive, and it was intriguing. What was the CEO of a direct-to-consumer company doing at an industry conference where the buyers were generally providers, employers and payers?
No comments